Text this: Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments

  ______    ______     _____     ___              
 /_____//  /_   _//   / ___//   / _ \\      ___   
 `____ `    -| ||-    \___ \\  / //\ \\    /   || 
 /___//     _| ||_    /    // |  ___  ||  | [] || 
 `__ `     /_____//  /____//  |_||  |_||   \__ || 
 /_//      `-----`  `-----`   `-`   `-`     -|_|| 
 `-`                                         `-`